DEMANTNasdaq CopenhagenMedical DevicesIFRS · DKK

Demant A/S

Demant A/S is a Denmark-based hearing healthcare company that develops, manufactures, and sells hearing aids, hearing solutions, and related hearing care products and services. Through its group structure, it serves both professional hearing-care channels and end users across global markets.

Ask about the company
Revenue23.0bn DKK
+2.5 %y/y
Operating profit (EBIT)3,832m DKK
−15.4 %y/y
EBIT margin16.7%
−3.5 ppy/y
Net income1,544m DKK
−35.3 %y/y
Free cash flow3,200m DKK
−8.7 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

0510152025bn DKK2020: 14.5 bn DKK2020: EBIT 1.5 bn DKK20202021: 18.4 bn DKK2021: EBIT 3.4 bn DKK20212022: 19.7 bn DKK2022: EBIT 3.2 bn DKK20222023: 22.4 bn DKK2023: EBIT 4.1 bn DKK20232024: 22.4 bn DKK2024: EBIT 4.5 bn DKK20242025: 23.0 bn DKK2025: EBIT 3.8 bn DKK202523.03.8
RevenueOperating profit (EBIT)
Ask Clarifo about Demant A/S

Business

Share of revenue
Hearing aids55 %

Core hearing devices sold through hearing-care channels and clinics.

Hearing care services20 %

Professional fitting, support, and aftercare linked to hearing aid use.

Audiology equipment15 %

Diagnostic and fitting equipment used by hearing-care professionals.

Hearing protection and communications10 %

Adjunct products for noise protection and workplace communication.

Customers

Demant sells primarily to hearing-care professionals, audiologists, clinics, and other channel partners that fit and dispense hearing solutions. It also reaches end users through hearing care services and related consumer-facing offerings, where fitting quality and long-term support are important purchase drivers.

Hearing-care professionals

Clinics, audiologists, and dispensers that buy hearing aids and fitting tools for patient care.

End users/patients

Individuals purchasing hearing solutions through professional channels or care services.

Diagnostic and hearing test providers

Customers that buy audiology equipment and workflow tools for testing and fitting.

Workplace and consumer protection buyers

Buyers of hearing protection and communication products for occupational or personal use.

Strategy

Demant's strategy is centered on broadening access to hearing healthcare through its product portfolio, service capabilities, and channel relationships. Competitive position depends on device quality, fitting outcomes, and the ability to serve professional hearing-care networks across multiple geographies.

Expand the hearing-care ecosystemMedium term

Combining devices, diagnostics, and services increases customer stickiness and channel relevance.

Deepen professional channel relationshipsShort term

Clinics and audiologists influence product selection and patient outcomes.

Broaden geographic reachMedium term

Diversified market exposure helps balance country-specific reimbursement and demand patterns.

Geography

Demant operates internationally, with sales distributed across Europe, North America, and other global markets. Geography matters because hearing-care demand, reimbursement frameworks, and channel structures differ by country, shaping both product mix and go-to-market approach.

Risks

Demant faces demand risk tied to hearing-care volumes, reimbursement conditions, and the pace at which patients seek treatment. It is also exposed to competitive pressure in premium hearing aids, product obsolescence, and channel dependence, since professional recommendations strongly influence sales.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Channel dependence1Reimbursement and market access changes2Competitive pricing and product substitution3Technology and innovation risk4
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Channel dependenceImpact: HighLikelihood: High

    Sales rely heavily on hearing-care professionals who influence product choice and adoption.

    Exposure: Professional dispensing channels

  2. Reimbursement and market access changesImpact: HighLikelihood: Medium

    Country-specific healthcare systems affect patient affordability and clinic demand.

    Exposure: Europe and North America

  3. Competitive pricing and product substitutionImpact: MediumLikelihood: High

    Hearing aids compete on technology, service, and brand, which can affect share.

    Exposure: Core hearing solutions

  4. Technology and innovation riskImpact: MediumLikelihood: Medium

    New digital features and fitting technologies can make existing products less competitive.

    Exposure: Product portfolio

Ask Clarifo about Demant A/S

Accounting

Judgemental items
Revenue recognition

Device sales, services, and channel deliveries may be recognized at different points in time.

Impact: Can shift quarterly revenue and gross margin mix

Goodwill and intangible impairment

Acquired hearing-care businesses and brands require ongoing impairment assessment.

Impact: Could create large non-cash charges if expectations weaken

Foreign exchange and hedging

International operations create transaction and translation exposure across currencies.

Impact: May affect revenue, costs, and equity reserves

Similar listed companies

Publicly listed companies with a comparable business focus.

Revenio Group Oyj

REG1V · Medical Devices

Nexstim Plc

NXTMH · Medical Devices

Bioretec Oy

BRETEC · Medical Devices

Modulight Oyj

MODU · Medical Devices

Arcoma

ARCOMA · Medical Devices

Braincool

BRAIN · Medical Devices

Last updated: 24/10/2026